Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the change in neuropsychological status from
baseline to 6 months post-initiation of atomoxetine treatment in children ages 6 to 10.5
diagnosed with ADHD.